Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
Effect of α2-Adrenergic Agonist Clonidine on Plasma Growth Hormone and Insulin-like Growth Factor-I Concentrations in Barrows
AKIHITO OZAWATETSU JOHKEKOICHI HODATE
Author information
JOURNAL FREE ACCESS

1995 Volume 42 Issue 5 Pages 669-673

Details
Abstract
The effects of infusion of clonidine, an α2-adrenergic agonist, on plasma insulin-like growth factor-I (IGF-I) concentrations were investigated with a single growth hormone (GH) injection in pigs. Four barrows were subjected to four treatments: saline infusion with a vehicle injection, clonidine infusion (0.5nmol/kg/min for 8h) with a vehicle injection, saline infusion with a bovine GH (bGH:100 μg/kg) injection, and clonidine infusion with a bGH injection. Infusion was started 1h before the injection. Plasma IGF-I, bGH, porcine GH (pGH), insulin, glucose, non-esterified fatty acid (NEFA), and blood urea nitrogen (BUN) concentrations were measured. Plasma IGF-I concentrations during saline infusion increased after a bGH injection (P<0.05). However, the IGF-1 concentrations during clonidine infusion did not increase after the bGH injection. Plasma endogenous GH (pGH) was not increased during clonidine infusion. The plasma glucose concentration was noticeably increased during clonidine infusion and moderately increased after the GH injection. Despite the extreme increase in plasma glucose during clonidine infusion, plasma insulin did not change. Neither plasma NEFA nor BUN was changed by these treatments. These results demonstrate that the α2-adrenergic agonist clonidine altered the action of GH to increase the plasma IGF-I concentrations.
Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top